Dimethyl 4-(4-chloro-3-nitrophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate | 103026-76-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: Dimethyl 4-(4-chloro-3-nitrophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate
• 英文别名: dimethyl 4-(4-chloro-3-nitrophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate
• CAS: 103026-76-2
• 化学式: C₁₇H₁₅ClN₂O₆
• 分子量: 378.769
• InChiKey: TWMQVSGXKQDJRV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  26
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  111
• 氢给体数：
  0
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  1,4-dihydro-2,6-dimethyl-4-(3-nitro-4-chlorophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester 在 硝酸 作用下， 反应 1.0h， 以68%的产率得到Dimethyl 4-(4-chloro-3-nitrophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate
  参考文献：
  名称：

  人肝微粒体对4-芳基和4-烷基取代的2,6-二甲基-3,5-双（烷氧基羰基）-1,4-二氢吡啶的氧化作用和涉及细胞色素P-450形式的免疫化学证据。

  摘要：

  4-取代的2,6-二甲基-3,5-双（烷氧基羰基）-1,4-二氢吡啶很重要，因为它们作为钙通道阻滞剂。检查了人肝微粒体对14个4-芳基和四个4-烷基取代的衍生物的混合功能氧化。所有4-芳基化合物的酶促氧化的主要产物是含有4-芳基的吡啶衍生物。相反，4-烷基化合物形成吡啶衍生物，其中在4-位存在氢原子并且烷基丢失；这些化合物还使细胞色素P-450失活，并在酶促氧化后导致硝苯地平氧化酶活性丧失。所有这些反应均受到针对纯化的人肝硝苯地平氧化酶细胞色素P-450（P-450NF）的抗体的抑制，表明该酶在这些化合物的氧化中起主要作用。4-烷基化合物的氧化不仅导致P-450NF的损失，而且还导致细胞色素P-450同工酶催化其他反应（非那西丁O-去乙基化和己糖3'-羟基化）的催化活性降低。结果表明，P-450NF（或密切相关的酶形式）负责人肝微粒体中这些硝苯地平相关化合物的氧化，并且代谢高度依赖于4-取

  DOI：

  10.1021/jm00159a007

文献信息

• Oxidation of 4-aryl- and 4-alkyl-substituted 2,6-dimethyl-3,5-bis(alkoxycarbonyl)-1,4-dihydropyridines by human liver microsomes and immunochemical evidence for the involvement of a form of cytochrome P-450
  作者：Ronald H. Boecker、F. Peter Guengerich

  DOI：10.1021/jm00159a007

  日期：1986.9

  lost; these compounds also inactivated cytochrome P-450 and caused the loss of nifedipine oxidase activity after enzymatic oxidation. All of these reactions were extensively inhibited by an antibody raised to purified human liver nifedipine oxidase cytochrome P-450 (P-450NF), indicating a major role for this enzyme in the oxidation of these compounds. Oxidation of the 4-alkyl compounds led not only

  4-取代的2,6-二甲基-3,5-双（烷氧基羰基）-1,4-二氢吡啶很重要，因为它们作为钙通道阻滞剂。检查了人肝微粒体对14个4-芳基和四个4-烷基取代的衍生物的混合功能氧化。所有4-芳基化合物的酶促氧化的主要产物是含有4-芳基的吡啶衍生物。相反，4-烷基化合物形成吡啶衍生物，其中在4-位存在氢原子并且烷基丢失；这些化合物还使细胞色素P-450失活，并在酶促氧化后导致硝苯地平氧化酶活性丧失。所有这些反应均受到针对纯化的人肝硝苯地平氧化酶细胞色素P-450（P-450NF）的抗体的抑制，表明该酶在这些化合物的氧化中起主要作用。4-烷基化合物的氧化不仅导致P-450NF的损失，而且还导致细胞色素P-450同工酶催化其他反应（非那西丁O-去乙基化和己糖3'-羟基化）的催化活性降低。结果表明，P-450NF（或密切相关的酶形式）负责人肝微粒体中这些硝苯地平相关化合物的氧化，并且代谢高度依赖于4-取
• Microwave assisted combinatorial chemistry synthesis of substituted pyridines
  作者：Ian C. Cotterill、Alexander Ya. Usyatinsky、John M. Arnold、Douglas S. Clark、Jonathan S. Dordick、Peter C. Michels、Yuri L. Khmelnitsky

  DOI：10.1016/s0040-4039(97)10796-1

  日期：1998.3

  (Microwave-assisted Combinatorial Synthesis) for generating combinatorial libraries is described. The technology is applied to the high throughput, automated, one-step, parallel synthesis of diverse substituted pyridines using the Hantzsch synthesis. The advantages of microwave-assisted chemistry for combinatorial synthesis include a broad range of available chemistries, simple reaction setup and product

  描述了一种用于生成组合库的新型高效MICROCOS技术（微波辅助组合合成）。该技术已应用于使用Hantzsch合成技术的高通量，自动化，一步一步，多种取代吡啶的并行合成中。微波辅助化学用于组合合成的优点包括广泛的可用化学方法，简单的反应设置和易于自动化的产物回收，极短的反应时间以及高产物收率。
• Oxidation of dihydropyridine calcium channel blockers and analogs by human liver cytochrome P-450 IIIA4
  作者：F. Peter Guengerich、William R. Brian、Masahiko Iwasaki、Marie Agnes Sari、Catharina Baeaernhielm、Peder Berntsson

  DOI：10.1021/jm00110a012

  日期：1991.6

  A series of 21 different 4-substituted 2,6-dimethyl-3-(alkoxycarbonyl)-1,4-dihydropyridines was considered with regard to oxidation to pyridine derivatives by human liver microsomal cytochrome P-450 (P-450). Antibodies raised against P-450 IIIA4 inhibited the microsomal oxidation of nifedipine and felodipine to the same extent, as did cimetidine and the mechanism-based inactivator gestodene. Gestodene was approximately 10(3) times more effective an inhibitor than cimetidine, on a molar basis. When rates of oxidation of the 1,4-dihydropyridines were compared to each other in different human liver microsomal preparations, all were highly correlated with each other with the exceptions of a derivative devoid of a substituent at the 4-position and an N1-CH3 derivative. A P-4.50 IIIA4 cDNA clone was expressed in yeast and the partially purified protein was used in reconstituted systems containing NADPH-cytochrome P-450 reductase and cytochrome b5. This system catalyzed the oxidation of all of the 1,4-dihydropyridines except the two for which poor correlation was seen in the liver microsomes. Principal component analysis supported the view that most of these reactions were catalyzed by the same enzyme in the yeast P-450 IIIA4 preparation and in the different human liver microsomal preparations, or by a closely related enzyme showing nearly identical properties of catalytic specificity and regulation. The results indicate that the enzyme P-450 IIIA4 is probably the major human catalyst involved in the formal dehydrogenation of most but not all 1,4-dihydropyridine drugs.